Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nir Uriel Added: 4 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more
Job title: Associate Physician
Dr Michelle O’Donoghue, is an Associate Physician in the Cardiology Division of Brigham and Women’s Hospital, an Affiliate Physician in the Cardiology Division of Massachusetts General Hospital and an Assistant Professor in Medicine at Harvard Medical School in Boston, Massachusetts, US. She is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, founded by Dr Eugene… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Chairman, Clinic of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany
Dr Axel Merseburger is the chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany.Dr Meseburger's areas of interest include renal, prostate, and transitional cell carcinoma, including novel biomarkers and prognostic factors. View more
Research Area(s) / Expertise:
Dr Erin Bohula, MD, DPhil is an Associate Physician in Cardiovascular Medicine at Brigham and Women's Hospital, an Instructor of Medicine at Harvard Medical School, and an Investigator at the TIMI Study Group. Dr Bohula research interests include the interplay of obesity, metabolic health and cardiovascular disease, evaluation of novel biomarkers and the application of innovative technologies for… View more
Research Area(s) / Expertise: Job title: Professor of Renal Medicine
Prof James Burton isHonorary Consultant Nephrologist and Professor of Renal Medicine and Associate Dean for Clinical Research at the University of Leicester, Leicester, UK. His principal research interests are the mechanisms underlying uraemic cardiovascular disease modification of cardiovascular risk in patients with end-stage renal disease and the identification and application of novel… View more